healthcare.digital August 19, 2024
Lloyd Price

Nelson Advisors Partner and HealthTech M&A Advisor Lloyd Price sharing his thoughts on the Revenue Cycle Management (RCM) market and USD $7Bn bid for R1 RCM with the team at MergerMarket

Revenue cycle management (RCM) has become one of the brightest stars in the healthcare technology firmament after the USD $7Bn bid for R1 RCM [NASDAQ:RCM] from private-equity groups TowerBrook Capital Partners and Clayton, Dubilier & Rice on 1st August.

The attraction is simple: Financial sponsors and strategics continue to see blue sky for growth both organically and through acquisition in a highly fragmented market that quite literally pays the bills in healthcare.

RCM software helps hospitals, doctors and other healthcare groups bill for services and collect payments.

“It’s clearly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Related Articles:
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article